Deepak Nitrite
Chemicals · DEEPAKNTR
Mid CapBasic MaterialsHigh Growth
Maulik D. Mehta
Chairman & Managing Director · Visionary
Company DNA
Founder-Centric
About
Deepak Nitrite is a Mid Cap company in the Basic Materials sector, listed on NSE as DEEPAKNTR. With a market cap of ₹20K Cr and revenue of ₹8K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Strong leadership influence under the Mehta family with a strategic growth mindset driven by long-term promoter vision. Its strategic mandate: Capitalizing on chemical import substitution trends requires aggressive R&D investment and expansion into high-margin specialty segments.
FAQ
What kind of company is Deepak Nitrite?
Deepak Nitrite is a Mid Cap Basic Materials company (DEEPAKNTR) in the High Growth phase with a market cap of ₹20K Cr. It is classified as Founder-Centric in culture.
What is Deepak Nitrite's culture and work environment like?
Deepak Nitrite has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Strong leadership influence under the Mehta family with a strategic growth mindset driven by long-term promoter vision.
Who leads Deepak Nitrite?
Deepak Nitrite is led by Maulik D. Mehta (Chairman & Managing Director), a Visionary leader with 10 years of experience.
What are Deepak Nitrite's financials?
Deepak Nitrite reported revenue of ₹8K Cr in FY25 with a 5-year revenue CAGR of 6.1%. Operating margin: 11.2%. Market cap: ₹20K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleHigh Growth
Strong leadership influence under the Mehta family with a strategic growth mindset driven by long-term promoter vision.
Mandate
Capitalizing on chemical import substitution trends requires aggressive R&D investment and expansion into high-margin specialty segments.
Capitalizing on chemical import substitution trends requires aggressive R&D investment and expansion into high-margin specialty segments.
Financials
Revenue FY25₹8K Cr
PAT FY25₹697 Cr
Rev CAGR 5Y6.1%
OPM11.2%
NPM8.6%
ROE12.9%
ROCE13.4%
P/E37
Fwd P/E27.5
P/B3.6
D/E22.4
Mkt Cap₹20K Cr
Promoter49.8%
Institutional24.8%
Similar Culture
Could You Lead Deepak Nitrite?
Take the Genome Benchmark →